Lazzero M - Search Results

1

Secco GG, Sansa M, Rognoni A, Parisi R, Fattori R, Rossi L, Lazzero M, Rolla R, Bellomo G, Bongo AS, Agostoni P, Di Mario C, Lupi A. Secco GG, et al. Among authors: lazzero m. J Cardiovasc Med (Hagerstown). 2015 Mar;16(3):189-96. doi: 10.2459/JCM.0000000000000119. J Cardiovasc Med (Hagerstown). 2015. PMID: 25022932 Clinical Trial.

2

Update on glycoprotein IIb/IIIa: role in primary coronary intervention.

Rognoni A, Lupi A, Secco GG, Cavallino C, Sansa M, Lazzero M, Bongo AS. Rognoni A, et al. Among authors: lazzero m. Cardiovasc Hematol Agents Med Chem. 2011 Apr 1;9(2):106-12. doi: 10.2174/187152511796196524. Cardiovasc Hematol Agents Med Chem. 2011. PMID: 21574947 Review.

3

Plasma fibrinogen levels and restenosis after primary percutaneous coronary intervention.

Lupi A, Secco GG, Rognoni A, Rossi L, Lazzero M, Nardi F, Rolla R, Bellomo G, Bongo AS, Di Mario C. Lupi A, et al. Among authors: lazzero m. J Thromb Thrombolysis. 2012 May;33(4):308-17. doi: 10.1007/s11239-011-0628-z. J Thromb Thrombolysis. 2012. PMID: 21909639

4

Below normal pre-procedural cardiac troponin I levels are associated with an adverse prognosis after percutaneous coronary interventions.

Lupi A, Rognoni A, Lazzero M, Rolla R, Pergolini P, Bellomo G, Rossi L, Sante Bongo A, Jaffe AS. Lupi A, et al. Among authors: lazzero m. EuroIntervention. 2016 Mar;11(12):1380-8. doi: 10.4244/EIJY14M11_04. EuroIntervention. 2016. PMID: 25405803 Free article.

5

Pre-hospital ticagrelor in patients with ST-segment elevation myocardial infarction with long transport time to primary PCI facility.

Lupi A, Schaffer A, Lazzero M, Tessitori M, De Martino L, Rognoni A, Bongo AS, Porto I. Lupi A, et al. Among authors: lazzero m. Cardiovasc Revasc Med. 2016 Dec;17(8):528-534. doi: 10.1016/j.carrev.2016.08.005. Epub 2016 Aug 20. Cardiovasc Revasc Med. 2016. PMID: 27666002

6

Drug-eluting stents vs. bare metal stents in saphenous vein graft disease. Insights from a meta-analysis of 7,090 patients.

Lupi A, Navarese EP, Lazzero M, Sansa M, De Servi S, Serra A, Bongo AS, Buffon A. Lupi A, et al. Among authors: lazzero m. Circ J. 2011;75(2):280-9. doi: 10.1253/circj.cj-10-0186. Epub 2010 Dec 14. Circ J. 2011. PMID: 21173499 Free article.

7

Safety and efficacy of the new Angio-Seal Evolution™ closure device: a single-center experience.

Lupi A, Lazzero M, Plebani L, Sansa M, Bongo AS. Lupi A, et al. Among authors: lazzero m. J Invasive Cardiol. 2011 Apr;23(4):150-5. J Invasive Cardiol. 2011. PMID: 21474848

8

Pharmacological adjuvant therapies in primary coronary interventions: bivalirudin.

Lupi A, Rognoni A, Cavallino C, Secco GG, Prando MD, Santagostino M, Lazzero M, Cassetti E, Bongo AS. Lupi A, et al. Among authors: lazzero m. Cardiovasc Hematol Agents Med Chem. 2013 Jun;11(2):106-14. doi: 10.2174/1871525711311020006. Cardiovasc Hematol Agents Med Chem. 2013. PMID: 22963495 Review.

9

Biodegradable versus durable polymer drug eluting stents in coronary artery disease: insights from a meta-analysis of 5,834 patients.

Lupi A, Rognoni A, Secco GG, Lazzero M, Nardi F, Fattori R, Bongo AS, Agostoni P, Sheiban I. Lupi A, et al. Among authors: lazzero m. Eur J Prev Cardiol. 2014 Apr;21(4):411-24. doi: 10.1177/2047487312467745. Epub 2012 Nov 14. Eur J Prev Cardiol. 2014. PMID: 23152364 Review.

10

Intracoronary bivalirudin: a new way to appease the hostile thrombus?

Lupi A, Porto I, Rognoni A, Secco GG, Parisi R, Genoni G, Lazzero M, Bongo AS. Lupi A, et al. Among authors: lazzero m. Blood Coagul Fibrinolysis. 2013 Oct;24(7):757-61. doi: 10.1097/MBC.0b013e328361bd2f. Blood Coagul Fibrinolysis. 2013. PMID: 23702838

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters